CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-29 | Ryan Charles S. Director | Grant or award · Stock Option | +75,000 | 75,000 | ||
| 2018-10-29 | Silva Francisco VP of Research and Development | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2018-10-29 | Clyde Mandy D. VP of Operations | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2018-10-29 | CATELL ROBERT B Director | Grant or award · Stock Option | +75,000 | 75,000 | ||
| 2018-10-29 | Weinreb Mark CEO and Chairman of the Board | Grant or award · Stock Option | +275,000 | 275,000 | ||
| 2018-10-29 | Desmarais John M Director | Grant or award · Stock Option | +75,000 | 75,000 | ||
| 2018-10-29 | Tonna Paul Jude Director | Grant or award · Stock Option | +75,000 | 75,000 | ||
| 2018-10-15 | ALSTODT LANCE EVP and Chief Strategy Officer | Grant or award · Stock Option | +500,000 | 500,000 | ||
| 2018-05-09 | CATELL ROBERT B Director | Purchase | +5,000 | $2.80 | $14K | 80,866 |
| 2018-01-19 | BERGSTEIN ADAM D. SVP, Planning and Business Dev | Grant or award · Stock Option | +500,000 | 500,000 | ||
| 2017-11-17 | Desmarais John M Director | Returned to the company · Warrant | −125,000 | 0 | ||
| 2017-11-17 | Desmarais John M Director | Grant or award · Warrant | +125,000 | 125,000 | ||
| 2017-11-17 | Desmarais John M Director | Returned to the company · Warrant | −250,000 | 0 | ||
| 2017-11-17 | Desmarais John M Director | Grant or award · Warrant | +250,000 | 250,000 | ||
| 2017-11-17 | Desmarais John M Director | Returned to the company · Warrant | −444,444 | 0 | ||
| 2017-11-17 | Desmarais John M Director | Grant or award · Warrant | +444,444 | 444,444 | ||
| 2017-11-17 | Desmarais John M Director | Returned to the company · Warrant | −400,000 | 0 | ||
| 2017-11-17 | Desmarais John M Director | Grant or award · Warrant | +400,000 | 400,000 | ||
| 2017-08-11 | CATELL ROBERT B Director | Grant or award · Warrant | +5,000 | 5,000 | ||
| 2017-08-10 | Clyde Mandy D. VP of Operations | Grant or award · Stock Option | +20,000 | 20,000 |
Page 23 of 35 · 690 trades